Vetriselvan Subramaniyan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Circular RNAs in diseases 2
-
- Computational Drug Discovery Methods 6
- Co-authors
- Waleed Hassan Almalki (3 shared papers)Riya Thapa (3 shared papers)Asif Ahmad Bhat (3 shared papers)Vinoth Kumarasamy (9 shared papers)Obaid Afzal (2 shared papers)Sami I. Alzarea (2 shared papers)Imran Kazmi (2 shared papers)Mahendran Sekar (9 shared papers)
- Journals
- Scientific Reports (4 papers)Toxicology Reports (3 papers)Cell Biochemistry and Biophysics (2 papers)Frontiers in Pharmacology (2 papers)Frontiers in Plant Science (1 paper)
- Partner nations
- IndiaMalaysiaSaudi Arabia
In The Last Decade
Vetriselvan Subramaniyan
29 papers receiving 494 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 128
- Molecular Medicine 42
- Aging 6
- Complementary and alternative medicine 28
- Biomaterials 44
Countries citing papers authored by Vetriselvan Subramaniyan
This map shows the geographic impact of Vetriselvan Subramaniyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vetriselvan Subramaniyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vetriselvan Subramaniyan more than expected).
Fields of papers citing papers by Vetriselvan Subramaniyan
This network shows the impact of papers produced by Vetriselvan Subramaniyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vetriselvan Subramaniyan. The network helps show where Vetriselvan Subramaniyan may publish in the future.
Co-authors
The 25 scholars most cited alongside Vetriselvan Subramaniyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 86 | |
| 2 | 2023 | 71 | |
| 3 | 2021 | 65 | |
| 4 | 2023 | 52 | |
| 5 | 2024 | 32 | |
| 6 | 2023 | 19 | |
| 7 | 2024 | 19 | |
| 8 | 2024 | 19 | |
| 9 | 2023 | 16 | |
| 10 | 2023 | 14 | |
| 11 | 2024 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2024 | 11 | |
| 14 | 2024 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2024 | 8 | |
| 17 | 2024 | 8 | |
| 18 | 2024 | 7 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 4 |
About Vetriselvan Subramaniyan
Vetriselvan Subramaniyan is a scholar working on Molecular Biology, Computational Theory and Mathematics, Pharmacology, Pharmaceutical Science and Nutrition and Dietetics, having authored 38 papers that have together received 500 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), Phytochemicals and Antioxidant Activities (4 papers), Drug Solubulity and Delivery Systems (3 papers), Cancer-related molecular mechanisms research (3 papers), Natural Antidiabetic Agents Studies (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Circular RNAs in diseases (2 papers) and Food composition and properties (2 papers). The work is most often cited by research in Cancer Research (128 citations), Molecular Medicine (42 citations), Aging (6 citations), Complementary and alternative medicine (28 citations) and Biomaterials (44 citations). Vetriselvan Subramaniyan has collaborated with scholars based in India, Malaysia and Saudi Arabia. Frequent co-authors include Waleed Hassan Almalki, Riya Thapa, Asif Ahmad Bhat, Vinoth Kumarasamy, Obaid Afzal, Sami I. Alzarea, Imran Kazmi, Mahendran Sekar, Kamal Dua and Sachin Kumar Singh. Their work appears in journals such as Scientific Reports, Toxicology Reports, Cell Biochemistry and Biophysics, Frontiers in Pharmacology and Frontiers in Plant Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.